ScoreWhy is Apyx Medical Corp. ?
1
Poor long term growth as Operating profit has grown by an annual rate 9.91% of over the last 5 years
2
With a growth in Net Sales of 34.75%, the company declared Very Positive results in Sep 25
- OPERATING CASH FLOW(Y) Highest at USD -8.42 MM
- PRE-TAX PROFIT(Q) Highest at USD -1.88 MM
- NET PROFIT(Q) Highest at USD -1.98 MM
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 225.23%, its profits have risen by 42.9%
4
High Institutional Holdings at 48.79%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
5
Market Beating Performance
- The stock has generated a return of 225.23% in the last 1 year, much higher than market (S&P 500) returns of 14.90%
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Apyx Medical Corp. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Apyx Medical Corp. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Apyx Medical Corp.
271.96%
1.14
103.33%
S&P 500
14.9%
0.77
19.29%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
14.23%
EBIT Growth (5y)
9.91%
EBIT to Interest (avg)
-12.91
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.33
Sales to Capital Employed (avg)
1.04
Tax Ratio
1.25%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
48.79%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
26.25
EV to EBIT
-17.19
EV to EBITDA
-18.30
EV to Capital Employed
10.39
EV to Sales
3.41
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-60.41%
ROE (Latest)
-248.36%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend19What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD -8.42 MM
PRE-TAX PROFIT(Q)
Highest at USD -1.88 MM
NET PROFIT(Q)
Highest at USD -1.98 MM
RAW MATERIAL COST(Y)
Fallen by -33.28% (YoY
OPERATING PROFIT(Q)
Highest at USD -0.67 MM
OPERATING PROFIT MARGIN(Q)
Highest at -5.19 %
EPS(Q)
Highest at USD -0.05
-3What is not working for the Company
ROCE(HY)
Lowest at -172.18%
DEBT-EQUITY RATIO
(HY)
Highest at 240.71 %
Here's what is working for Apyx Medical Corp.
Pre-Tax Profit
Highest at USD -1.88 MM and Grown
In each period in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (USD MM)
Net Profit
Highest at USD -1.98 MM and Grown
In each period in the last five periodsMOJO Watch
Near term Net Profit trend is very positive
Net Profit (USD MM)
Operating Cash Flow
Highest at USD -8.42 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Operating Profit
Highest at USD -0.67 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (USD MM)
Operating Profit Margin
Highest at -5.19 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Pre-Tax Profit
At USD -1.88 MM has Grown at 59.76%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (USD MM)
Net Profit
At USD -1.98 MM has Grown at 57.81%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
EPS
Highest at USD -0.05
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (USD)
Raw Material Cost
Fallen by -33.28% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Apyx Medical Corp.
Debt-Equity Ratio
Highest at 240.71 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
